Breaking News Instant updates and real-time market news.

MNKD

MannKind

$1.25

0.025 (2.05%)

, ROST

Ross Stores

$94.11

0.69 (0.74%)

10:06
05/14/19
05/14
10:06
05/14/19
10:06

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MannKind (MNKD) initiated with a Buy, $3 price target at BTIG. 2. Ross Stores (ROST) and TJX (TJX) initiated with an Outperform at Baird. 3. Elastic (ESTC) initiated with a Hold at Stifel. 4. CytomX Therapeutics (CTMX) initiated with an Overweight at Cantor Fitzgerald. 5. FIS (FIS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

MNKD

MannKind

$1.25

0.025 (2.05%)

ROST

Ross Stores

$94.11

0.69 (0.74%)

TJX

TJX

$52.61

0.13 (0.25%)

ESTC

Elastic

$83.31

0.325 (0.39%)

CTMX

CytomX Therapeutics

$10.98

0.15 (1.39%)

FIS

FIS

$116.44

0.95 (0.82%)

  • 14

    May

  • 14

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 04

    Jun

  • 10

    Jun

  • 13

    Nov

MNKD MannKind
$1.25

0.025 (2.05%)

05/14/19
BTIG
05/14/19
INITIATION
Target $3
BTIG
Buy
MannKind initiated with a Buy, $3 price target at BTIG
BTIG analyst Robert Hazlett initiated coverage of MannKind with a Buy rating and $3 price target. The stock closed Monday down 2c to $1.23. With the advancements of continuous glucose monitor technologies, tighter glycemic control will become more of a focus, and MannKind's Afrezza "can play a material role," Hazlett tells investors in a research note. The analyst estimates inhaled insulin Afrezza's peak U.S. sales at greater than $350M. Mannkind's recently revamped management is attempting to energize Afrezza through publications of differentiating data, which can improve acceptance among physicians and patients, helping "solid growth continue," according to Hazlett.
03/04/19
LEER
03/04/19
INITIATION
Target $3
LEER
Outperform
MannKind initiated with an Outperform at SVB Leerink
SVB Leerink initiated MannKind with an Outperform and $3 price target.
05/08/19
HCWC
05/08/19
NO CHANGE
Target $3
HCWC
Buy
MannKind price target lowered to $3 from $4 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat lowered his price target for MannKind to $3 from $4 saying that while Q2 is already shaping up better than Q1, the slower Afrezza ramp drives an estimate reduction. The analyst, however, still believes MannKind's pipeline "is all potential upside" to his model. He keeps a Buy rating on the shares.
03/04/19
03/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MannKind (MNKD) initiated with an Outperform at SVB Leerink. 2. Invitae (NVTA) initiated with a Buy at Chardan. 3. Immunomedics (IMMU) initiated with a Buy at H.C. Wainwright. 4. Canopy Growth (CGC) initiated with a Neutral at Melius Research. 5. Alector (ALEC) initiated with an Overweight at Morgan Stanley and Barclays, an Outperform at SVB Leerink and Cowen, as well as a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ROST Ross Stores
$94.11

0.69 (0.74%)

03/07/19
DADA
03/07/19
NO CHANGE
Target $92
DADA
Neutral
Ross Stores price target raised to $92 from $84 at DA Davidson
DA Davidson analyst John Morris raised his price target on Ross Stores to $92 but kept his Neutral rating, saying that while its Q4 earnings topped consensus, gross margins missed estimates as a result of higher freight and labor costs. The analyst also cites the management's more cautious commentary on Q1 "because women's (segment) is underperforming into the spring season" as a factor in his neutral stance.
05/14/19
BARD
05/14/19
INITIATION
Target $108
BARD
Outperform
Ross Stores initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated Ross Stores with an Outperform rating and $108 price target, telling investors in a research note that "there is a lot to like" about the off-price retailer, including "strong" management, "consistent" comp growth and "healthy" margins. While recent executive turnover adds a risk factor, the analyst says he sees a "deep bench" and thinks shares offer a good "deal" for investors looking for a high-quality/growth retailer trading at reasonable valuation.
05/13/19
BARD
05/13/19
INITIATION
Target $108
BARD
Outperform
Ross Stores initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated Ross Stores with an Outperform and $108 price target.
05/06/19
LOOP
05/06/19
NO CHANGE
Target $200
LOOP
Buy
Burlington Stores price target raised to $200 from $185 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Burlington Stores (BURL) to $200 and kept her Buy, citing the appointment of Michael O'Sullivan as new CEO, whom she considers to be a "great fit". The analyst cites O'Sullivan's experience at Ross Stores (ROST), where he contributed to its ladies' apparel and home goods categories performance - areas where Burlington Stores "remains underpenetrated." Champine lowers her Q1 comps forecast to flat from 2% but also raises her long-term estimate to 2.5% from 2%.
TJX TJX
$52.61

0.13 (0.25%)

02/28/19
UBSW
02/28/19
NO CHANGE
Target $43
UBSW
Sell
UBS maintains Sell rating on TJX citing growth sustainability
UBS analyst Jay Sole maintained his Sell rating on TJX shares as he believes the company is not doing enough to keep up with the changes in the retail industry. The analyst noted its annual earnings growth has occurred in an almost ideal off-price environment, but he believes the growth rate will be more difficult to maintain in the future. Sole raised his price target on TJX shares to $43 from $42 following the company's quarterly report.
05/13/19
BARD
05/13/19
INITIATION
Target $63
BARD
Outperform
TJX initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated TJX with an Outperform and $63 price target.
05/14/19
BARD
05/14/19
INITIATION
Target $63
BARD
Outperform
TJX initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated TJX with an Outperform rating and $63 price target, saying he thinks TJX can sustain at least mid single digit-high single digit EPS growth long-term supported by low single digit-mid single digit comps, unit growth and "steady" buybacks.
04/11/19
ARGS
04/11/19
NO CHANGE
Target $62
ARGS
Buy
TJX price target raised to $62 from $55 at Argus
Argus analyst Chris Graja raised his price target on TJX to $62 and kept his Buy rating, citing the company's "exceptional financial strength, efficient cost structure, and ability to deliver value-priced merchandise in a competitive retail environment." The analyst also points to TJX's 22 consecutive years of comps increases with only one year of decline in all of its 42-year history, its growing store traffic, and its 23 straight years of rising dividends. Graja adds that while retail is pressured by the internet competition, the "off-price" sector is the industry's strongest segment, with TJX being "better positioned to compete than most" retailers.
ESTC Elastic
$83.31

0.325 (0.39%)

04/02/19
FBNS
04/02/19
INITIATION
Target $95
FBNS
Outperform
Elastic initiated with an Outperform at FBN Securities
FBN Securities analyst Shebly Seyrafi initiated Elastic with an Outperform and $95 price target.
04/04/19
KEYB
04/04/19
INITIATION
Target $102
KEYB
Overweight
Elastic initiated with an Overweight at KeyBanc
KeyBanc analyst Brent Bracelin started coverage of Elastic with an Overweight rating and a $102 price target. The analyst believes the company has emerged as the leading modern search platform benefiting from a broad number of enterprise use-cases and forecasts revenue that can quadruple to $1B-plus within five years driven by an open-ended growth opportunity within a large $45B TAM.
03/05/19
OPCO
03/05/19
INITIATION
OPCO
Outperform
Elastic initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ittai Kidron initiated Elastic with an Outperform rating and $110 price target. The analyst believes Elastic is "strongly positioned to benefit from favorable secular trends driving enterprise digitization and the growing influence of developers on IT spending decisions; is exposed to a large and growing TAM with expansion opportunities into AI/ML, analytics, and other use cases; and will continue to successfully execute on its land-and-expand model, adding new customers and driving deeper penetration into existing customers."
05/13/19
STFL
05/13/19
INITIATION
Target $75
STFL
Hold
Elastic initiated with a Hold at Stifel
Stifel analyst Brad Reback initiated Elastic with a Hold rating and $75 price target, stating that he believes Elastic can grow its share of the unstructured data analytics market and sustain recurring revenue growth of over 30% along with margin expansion over the coming years. However, he views the shares as fully valued and does not foresee material room for further multiple expansion from current levels.
CTMX CytomX Therapeutics
$10.98

0.15 (1.39%)

05/13/19
NOMU
05/13/19
NO CHANGE
Target $22
NOMU
Buy
CytomX Therapeutics price target lowered to $22 from $44 at Nomura Instinet
Nomura Instinet analyst Christopher Marai halved his price target for CytomX Therapeutics to $22 but remains a buyer of the stock following the company's Q1 results. Clarification on the '2009 path forward and consistent with CX-072 data will drive share value in 2019 off near all-time-lows, Marai tells investors in a research note. His reduced price target reflects the longer than anticipated trials for '2009 and "limited" '072 updates.
05/14/19
CANT
05/14/19
INITIATION
Target $21
CANT
Overweight
Cantor starts CytomX with Overweight, sees 'compelling' risk/reward
Cantor Fitzgerald analyst Varun Kumar last night initiated coverage of CytomX Therapeutics with an Overweight rating and $21 price target. The company's lead early-stage clinical assets, based on modified antibodies, are "partially derisked and are highly discounted at the current valuation," Kumar tells investors in a research note. For CX-2009, the analyst thinks clinical updates over the next year months should alleviate investor concerns about its safety profile and that risk of a potential clinical setback is overstated. He sees a "compelling" risk/reward for shares of CytomX.
03/11/19
03/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. TCR2 Therapeutics (TCRR) initiated with an Outperform at SVB Leerink, Wedbush, and BMO Capital, while being initiated with a Buy at Jefferies. 2. Barings BDC (BBDC) resumed with an Outperform at Wells Fargo. 3. Avedro (AVDR) initiated with an Overweight at JPMorgan while being initiated with an Outperform at SVB Leerink and Cowen. 4. Anchiano Therapeutics (ANCN) initiated with a Buy at Ladenburg and an Outperform at Oppenheimer. 5. CytomX Therapeutics (CTMX) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/13/19
CANT
05/13/19
INITIATION
CANT
Overweight
CytomX Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated CytomX Therapeutics with an Overweight rating and $21 price target.
FIS FIS
$116.44

0.95 (0.82%)

05/03/19
CANT
05/03/19
DOWNGRADE
Target $119
CANT
Neutral
Worldpay downgraded to Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi downgraded Worldpay (WP) to Neutral from Overweight while raising his price target for the shares to $119 from $110. The analyst cites the company's upcoming merger with FIS (FIS) for the rating change.
05/14/19
BOFA
05/14/19
INITIATION
Target $139
BOFA
Buy
FIS reinstated with a Buy on deal synergies at BofA/Merrill
BofA/Merrill analyst Jason Kupferberg reinstated FIS (FIS) with a Buy and $139 price target following the announcement it plans to merge with Worldpay (WP). The analyst said the merger creates a "powerhouse" in technology and processing solutions across Payments and financial services. He believes initial synergy projections will prove conservative and views FIS' valuation represents favorable risk/reward.
05/03/19
CHLM
05/03/19
DOWNGRADE
Target $130
CHLM
Hold
Worldpay downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Bradley Berning downgraded Worldpay (WP) to Hold from Buy with a $130 price target following Thursday's Q1 earnings. In a research note to investors, Berning says he expects the FIS (FIS) deal to close in the second half of the year and for Worldpay to "largely" trade off on news related to the deal.
05/14/19
BOFA
05/14/19
INITIATION
Target $139
BOFA
Buy
FIS initiated with a Buy at BofA/Merrill
BofA/Merrill initiated FIS with a Buy and $139 price target.

TODAY'S FREE FLY STORIES

CNC

Centene

$55.45

-1.33 (-2.34%)

, WCG

WellCare

$274.46

-3.54 (-1.27%)

16:45
05/23/19
05/23
16:45
05/23/19
16:45
Hot Stocks
Centene, WellCare announce special meeting date, transaction to close by 1H20 »

Centene (CNC) and…

CNC

Centene

$55.45

-1.33 (-2.34%)

WCG

WellCare

$274.46

-3.54 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 23

    Jul

DVAX

Dynavax

$6.36

(0.00%)

16:42
05/23/19
05/23
16:42
05/23/19
16:42
Hot Stocks
Breaking Hot Stocks news story on Dynavax »

Dynavax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

DNKEY

Danske Bank

$0.00

(0.00%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Downgrade
Danske Bank rating change  »

Danske Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WD

Walker & Dunlop

$51.59

-0.92 (-1.75%)

16:39
05/23/19
05/23
16:39
05/23/19
16:39
Hot Stocks
Walker & Dunlop President Howard Smith sells $4M in company shares »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.01

1.05 (1.91%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Downgrade
Toronto-Dominion rating change  »

Toronto-Dominion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

16:36
05/23/19
05/23
16:36
05/23/19
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 5/13 Money Supply…

GWGH

GWG Holdings

$15.25

0.05 (0.33%)

16:36
05/23/19
05/23
16:36
05/23/19
16:36
Hot Stocks
GWG Holdings receives noncompliance notification from Nasdaq »

GWG Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSA

National Storage

$29.80

-0.195 (-0.65%)

16:35
05/23/19
05/23
16:35
05/23/19
16:35
Hot Stocks
National Storage 'elevates' its CEO Arlen Nordhagen to Executive Chairman »

National Storage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

16:34
05/23/19
05/23
16:34
05/23/19
16:34
General news
Fed Balance Sheet Level data reported »

Week of 5/22 Fed Balance…

MOS

Mosaic

$21.62

-0.72 (-3.22%)

16:32
05/23/19
05/23
16:32
05/23/19
16:32
Hot Stocks
Mosaic doubles quarterly dividend to 5c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Nov

ATIS

Attis Industries

$2.15

0.31 (16.85%)

16:32
05/23/19
05/23
16:32
05/23/19
16:32
Hot Stocks
Attis Industries notified by Nasdaq of delinquent Q1 10-Q filing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLMN

Falcon Minerals

$7.36

-0.26 (-3.41%)

16:32
05/23/19
05/23
16:32
05/23/19
16:32
Initiation
Falcon Minerals initiated  »

Falcon Minerals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRPX

Therapix Biosciences

$3.24

-0.03 (-0.92%)

16:31
05/23/19
05/23
16:31
05/23/19
16:31
Hot Stocks
Therapix Biosciences receives Nasdaq noncompliance notification »

Therapix Biosciences Ltd.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$20.96

-0.42 (-1.96%)

16:30
05/23/19
05/23
16:30
05/23/19
16:30
Hot Stocks
AXA Equitable raises quarterly dividend to 15c from 13c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 11

    Jun

DIS

Disney

$132.78

-1.06 (-0.79%)

16:28
05/23/19
05/23
16:28
05/23/19
16:28
Periodicals
ESPN's Pitaro says 'all hands on deck' to draw younger viewers, Bloomberg says »

ESPN president Jimmy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    Jun

CALX

Calix

$6.38

-0.25 (-3.77%)

16:27
05/23/19
05/23
16:27
05/23/19
16:27
Hot Stocks
Calix director Kevin Denuccio purchases over $221K in company shares »

Calix director Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BBY

Best Buy

$65.79

-3.47 (-5.01%)

, AAPL

Apple

$179.67

-2.94 (-1.61%)

16:25
05/23/19
05/23
16:25
05/23/19
16:25
On The Fly
Fly Intel: Wall Street's top stories for Thursday »

Stocks suffered losses…

BBY

Best Buy

$65.79

-3.47 (-5.01%)

AAPL

Apple

$179.67

-2.94 (-1.61%)

FB

Facebook

$180.89

-4.36 (-2.35%)

AVP

Avon Products

$3.61

-0.46 (-11.30%)

MAXR

Maxar Technologies

$8.84

1.69 (23.64%)

BX

Blackstone

$41.14

-0.56 (-1.34%)

PLD

Prologis

$76.44

-0.13 (-0.17%)

LB

L Brands

$24.27

-0.02 (-0.08%)

GWR

Genesee & Wyoming

$94.01

7.945 (9.23%)

BLMN

Bloomin' Brands

$18.22

-1.98 (-9.80%)

CMG

Chipotle

$666.31

-39.74 (-5.63%)

NTAP

NetApp

$61.65

-0.93 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 06

    Jun

  • 11

    Jun

  • 11

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 22

    Aug

  • 13

    Nov

BX

Blackstone

$41.14

-0.56 (-1.34%)

, BAM

Brookfield

$46.55

-0.25 (-0.53%)

16:23
05/23/19
05/23
16:23
05/23/19
16:23
Periodicals
Genesee & Wyoming pursued by Blackstone, Brookfield, others, Bloomberg says »

Blackstone (BX),…

BX

Blackstone

$41.14

-0.56 (-1.34%)

BAM

Brookfield

$46.55

-0.25 (-0.53%)

GWR

Genesee & Wyoming

$94.01

7.945 (9.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 19

    Jun

  • 08

    Aug

  • 13

    Nov

MFIN

Medallion Financial

$6.44

0.06 (0.94%)

16:22
05/23/19
05/23
16:22
05/23/19
16:22
Syndicate
Breaking Syndicate news story on Medallion Financial »

Medallion Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

RVEN

Reven Housing

$4.15

0.1 (2.47%)

16:21
05/23/19
05/23
16:21
05/23/19
16:21
Syndicate
Reven Housing requests withdrawal of registration statement »

The company is requesting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

DWDP

DowDuPont

$30.94

-0.8 (-2.52%)

, DD

Changed to DWDP

$0.00

(0.00%)

16:20
05/23/19
05/23
16:20
05/23/19
16:20
Hot Stocks
DowDuPont to change name, stock symbol »

The company confirmed…

DWDP

DowDuPont

$30.94

-0.8 (-2.52%)

DD

Changed to DWDP

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 29

    May

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

16:20
05/23/19
05/23
16:20
05/23/19
16:20
Hot Stocks
DXC Technology raises quarterly dividend to 21c from 19c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/23/19
05/23
16:20
05/23/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$15.96

-0.06 (-0.37%)

, LGF.B

Lionsgate

$15.08

-0.12 (-0.79%)

16:19
05/23/19
05/23
16:19
05/23/19
16:19
Hot Stocks
Breaking Hot Stocks news story on Lionsgate, Lionsgate »

Lionsgate down 8.7% to…

LGF.A

Lionsgate

$15.96

-0.06 (-0.37%)

LGF.B

Lionsgate

$15.08

-0.12 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

GMED

Globus Medical

$40.59

-0.84 (-2.03%)

16:19
05/23/19
05/23
16:19
05/23/19
16:19
Hot Stocks
Globus Medical announces results of ExcelsiusGPS clinical study published »

Globus Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.